As food becomes less stimulating, GLP-1 users are gravitating toward this pricey obsession.

The foods you eat every day may be quietly rewriting your hunger, energy, and metabolism in ways you ...

The rising use of GLP-1 agonists to help manage the obesity epidemic is not only reshaping how consumers taking the medication approach food, but it is also raising awareness among the broader ...

Share on Pinterest Research shows that GLP-1s may help lower blood pressure levels. Image Credit: Tatiana Maksimova/Getty Images A recent study found that GLP-1 drugs like Ozempic and Wegovy may ...

While GLP-1 medications first gained visibility for diabetes care and later for weight loss, researchers are now evaluating how they may benefit other areas of health connected to metabolic function.

GLP-1 weight-loss drugs alter brain circuits in the amygdala and dopamine system to reduce the motivation to seek out high-calorie foods.

GLP-1 medications are popular these days, but the body already naturally produces its own GLP-1. Dr. Mercola, a board-certified family medicine osteopathic physician (DO) and multi-best-selling author ...

GLP-1 receptor agonists, already used for Type 2 diabetes and obesity, show promise in reducing alcohol and drug-seeking ...

COYA 303 is an investigational biologic combination of COYA 301, Coya’s low-dose interleukin 2 (LD IL-2) and a GLP-1 receptor agonist (GLP-1RA), designed to deliver a multi-targeted immunomodulatory ...

AUSTIN, Texas, May 11, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Obesity and type 2 diabetes mellitus (T2DM) have become two of the most pressing healthcare challenges worldwide, driving ...

ColonBroom is taking a more targeted approach. The company has launched an upgraded version of its GLP-1 Premium formula, designed to support appetite control, digestive function, and long-term ...